Products

Tirzepatide

A dual GIP and GLP-1 receptor agonist designed to support research into metabolic regulation through complementary incretin signaling pathways.

Request information

Leave your email and our team will contact you about Tirzepatide.

These products are intended for research and laboratory use only. Not intended for human or veterinary use. Not for diagnostic or therapeutic procedures. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.

Estimate delivery times: 12-26 days (International), 3-6 days (United States).

Description

A dual GIP and GLP-1 receptor agonist designed to support research into metabolic regulation through complementary incretin signaling pathways.

Key Benefits: Supports research into appetite regulation, satiety, glucose homeostasis, energy utilization, metabolic function, and body composition.

Tirzepatide is typically administered under medical supervision, with dosing protocols tailored to individual health goals and clinical evaluation.